» Articles » PMID: 19596270

Mature Interleukin-33 is Produced by Calpain-mediated Cleavage in Vivo

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2009 Jul 15
PMID 19596270
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Interleukin (IL)-33 is a novel member of the IL-1 family. IL-33 is primarily synthesized as a 30-kDa precursor (pro-IL-33). Pro-IL-33 is cleaved by caspase-1 into an 18-kDa mature form (mature IL-33) in vitro. Recombinant mature IL-33 has been known to induce T-helper type-2 (Th2)-associated cytokines and inflammatory cytokines via its receptor, ST2L. However, processing of pro-IL-33 in vivo has not been clarified yet. Here, we report that calpain mediates pro-IL-33 processing in vivo. Pro-IL-33 was expressed by stimulating human epithelial cells with phorbol 12-myristate 13-acetate. Calcium ionophore induced pro-IL-33 cleavage and mature IL-33 production. This cleavage was inhibited by treatment with a calcium chelator and calpain inhibitors. Moreover, short interfering RNA-mediated knockdown of calpains suppressed pro-IL-33 cleavage. These results indicate that calpains play a critical role in pro-IL-33 processing in vivo.

Citing Articles

IL-33/ST2 axis in diverse diseases: regulatory mechanisms and therapeutic potential.

Sheng F, Li M, Yu J, Yang S, Zou L, Yang G Front Immunol. 2025; 16:1533335.

PMID: 39925809 PMC: 11802536. DOI: 10.3389/fimmu.2025.1533335.


Cholinergic sensing of allergen exposure by airway epithelium promotes type 2 immunity in the lungs.

Hayashi R, Srisomboon Y, Iijima K, Maniak P, Tei R, Kobayashi T J Allergy Clin Immunol. 2023; 153(3):793-808.e2.

PMID: 38000698 PMC: 10939907. DOI: 10.1016/j.jaci.2023.10.031.


The Correlation of Serum Calpain 1 Activity and Concentrations of Interleukin 33 in COVID-19 Acute Respiratory Distress Syndrome.

Loinjak D, Mihic D, Smolic R, Maricic L, Sahinovic I, Smolic M Biomedicines. 2023; 11(7).

PMID: 37509486 PMC: 10376760. DOI: 10.3390/biomedicines11071847.


Initiation of type 2 immunity at barrier surfaces.

McDaniel M, Lara H, von Moltke J Mucosal Immunol. 2023; 16(1):86-97.

PMID: 36642383 PMC: 10290812. DOI: 10.1016/j.mucimm.2022.11.002.


Emerging Effects of IL-33 on COVID-19.

Gao Y, Cai L, Li L, Zhang Y, Li J, Luo C Int J Mol Sci. 2022; 23(21).

PMID: 36362440 PMC: 9658128. DOI: 10.3390/ijms232113656.